CDKN2A and neoplasm: Further, a senescence-associated β-gal assay showed no staining difference in KRAS4AG12V and KRAS4BG12V tumors, suggesting that tumor suppression in KRAS4AG12V tumors by upregulated p16INK4A is not mediated by cellular senescence (Figure 6B).